PRESS RELEASE published on 05/21/2024 at 22:15, 2 years 3 months ago Nanobiotix annonce des avancees de la collaboration globale de developpement autour de NBTXR3 refletant son pipeline robuste et son approche de croissance sur le long terme Nanobiotix annonce des avancées de la collaboration globale de développement autour de NBTXR3 reflétant son pipeline robuste et son approche de croissance sur le long terme Croissance À Long Terme NANOBIOTIX NBTXR3 Collaboration Globale Pipeline Robuste
PRESS RELEASE published on 05/21/2024 at 22:00, 2 years 3 months ago Inventiva publie ses informations financières du 1 ? ? trimestre 2024¹ et fait un point sur ses activités Inventiva publie ses informations financières du 1er trimestre 2024 et fait un point sur ses activités. Trésorerie de 11,0 millions d'euros, dépôt long terme à 19,1 millions d'euros. Recommandation de poursuivre l'essai clinique de phase III NATiV3. Première visite du dernier patient prévue pour le premier semestre 2024 Chiffre D'affaires Trésorerie Essai Clinique Inventiva NATiV3
PRESS RELEASE published on 05/21/2024 at 22:00, 2 years 3 months ago Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update Inventiva reports 2024 First Quarter Financial Information and corporate update, including cash, deposits, and clinical trial progress. Company actively seeking financing options Financial Information Deposits Clinical Trial Cash Inventiva
PRESS RELEASE published on 05/21/2024 at 21:36, 2 years 3 months ago Inside Information / Other news releases Sopra Steria Group's Combined General Meeting chaired by Pierre Pasquier in Paris approved 34 resolutions. Detailed results available on the Group's website Shareholders General Meeting Resolutions Sopra Steria Group Pierre Pasquier
PRESS RELEASE published on 05/21/2024 at 21:36, 2 years 3 months ago Informations privilégiées / Autres communiqués L'Assemblée générale mixte des actionnaires de Sopra Steria Group approuve les 34 résolutions proposées. Tous les détails sur le site web du Groupe Actionnaires Resolutions Assemblée Générale Mixte Approbation Sopra Steria Group
PRESS RELEASE published on 05/21/2024 at 21:15, 2 years 3 months ago LUCIBEL LÈVE 1,95 M EUR PAR AUGMENTATION DE CAPITAL POUR SOUTENIR SON DÉVELOPPEMENT Lucibel annonce une augmentation de capital réussie de 1,95 M€, renforçant ses finances pour la croissance stratégique. Détails sur la demande d'actions et les objectifs futurs de l'entreprise Croissance Actionnaires Augmentation De Capital Finances Lucibel
PRESS RELEASE published on 05/21/2024 at 21:03, 2 years 3 months ago Siyata Introduces First of Its Kind AI Deep Learning PTT Device Siyata Mobile Inc. introduces the SD7 Wired Palm Mic Pro with AI Noise Cancellation for clearer communication in noisy environments, targeting first responders & enterprise customers Push-to-Talk Over Cellular Communication Siyata Mobile Inc. AI Noise Cancellation SD7 Wired Palm Mic Pro
PRESS RELEASE published on 05/21/2024 at 20:20, 2 years 3 months ago Atos - Market Update 21 May 2024 Atos extends deadline for Annual General Meeting to approve 2023 financial statements to December 31, 2024, to facilitate ongoing discussions on financial restructuring agreement by July 2024 Annual General Meeting Financial Statements Financial Restructuring Atos Deadline Extension
PRESS RELEASE published on 05/21/2024 at 20:20, 2 years 3 months ago Atos - Point de Marché 21 mai 2024 Atos prolonge le délai de réunion de l'Assemblée Générale pour discussions sur un accord de restructuration financière jusqu'au 31 décembre 2024. Comptes certifiés sans réserve Restructuration Financière Dilution Actionnaires Comptes Sociaux Atos Réunion Assemblée Générale
PRESS RELEASE published on 05/21/2024 at 20:15, 2 years 3 months ago Ad Hoc Announcement pursuant to clause 16 BX-Listing Rules of 21.05.2024 - Extraordinary General Meeting of 12 June 2024 ESGTI AG announces Extraordinary General Meeting on 12 June 2024 to split current share capital and revise Articles of Association in accordance with new company law Extraordinary General Meeting Articles Of Association ESGTI AG Share Capital Split New Company Law
Published on 09/12/2026 at 02:35, 18 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 3 hours 53 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 4 hours 48 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 5 hours 28 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 9 hours 53 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 22:15, 4 hours 38 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 4 hours 43 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 7 hours 9 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 8 hours 38 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 19 hours 53 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 19 hours 53 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 19 hours 53 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 19 hours 53 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 7 hours ago Availability of the 2026 Interim Financial Report